Comparison

Tauro-Obeticholic acid European Partner

Item no. TMO-T13092-25mg
Manufacturer TargetMol
CASRN 863239-61-6
Amount 25mg
Category
Type Molecules
Specific against other
Purity 99.82%
Citations Markham A, et al. Obeticholic Acid: First Global Approval. Drugs. 2016 Aug;76(12):1221-6.
Smiles C[C@H](CCC(NCCS(=O)(O)=O)=O)[C@H]1CC[C@@]2([H])[C@]3([H])[C@H](O)[C@H](CC)[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 863239-61-6, FXR
Available
Short Description
Tauro-Obeticholic acid is an active Obeticholic acid metabolite. Obeticholic acid is an orally bioavailable agonist of farnesoid-X receptor (FXR).
Shipping
cool pack
Storage
-20°
Molecular Weight
527, 76
Pathway
Metabolism
Target
FXR

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close